Effect of duloxetine 60 mg to 120 mg once daily in patients with chronic low back pain
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Duloxetine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 01 Jun 2010 Results were published in Spine.
- 13 Nov 2008 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
- 09 Oct 2008 Checked against the ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History